Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II…

Continue Reading Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial